Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for
Viral V. kapadia
Your search for
Viral V. Kapdia
retrieved no results
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
N Engl J Med. 2022 Feb 10;386(6):531-543. doi: 10.1056/NEJMoa2116185. Epub 2021 Dec 15.
N Engl J Med. 2022.
PMID: 34910859
Free PMC article.
Clinical Trial.
Ten moderate and 4 severe cases occurred, all in placebo recipients, yielding vaccine efficacy against moderate-to-severe disease of 100% (95% CI, 87.0 to 100). Most sequenced viral genomes (48 of 61, 79%) were variants of concern or interest - largely B.1.1.7 (alpha) (31 …
Ten moderate and 4 severe cases occurred, all in placebo recipients, yielding vaccine efficacy against moderate-to-severe disease of 100% (9 …
Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.
Gangappa S, Kapadia SB, Speck SH, Virgin HW 4th.
Gangappa S, et al.
J Virol. 2002 Nov;76(22):11460-8. doi: 10.1128/jvi.76.22.11460-11468.2002.
J Virol. 2002.
PMID: 12388707
Free PMC article.
While antiviral antibody plays a key role in resistance to acute viral infection, the contribution of antibody to the control of latent virus infection is less well understood. ...Passive transfer of antibody specific for the lytic cycle gammaHV68 RCA protein, but not pass …
While antiviral antibody plays a key role in resistance to acute viral infection, the contribution of antibody to the control of late …
Item in Clipboard
Cite
Cite